Back to search

Japan· JP-3969019F1086

ダパグリフロジンプロピレングリコール水和物

A dapagliflozin product containing ダパグリフロジンプロピレングリコール水和物, registered in Japan by ニプロ, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

On Japan’s NHI price listATC A10BK01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedダパグリフロジンプロピレングリコール水和物ATCA10BK01REGISTER NO.JP-3969019F1086PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Dapagliflozin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BK01 (dapagliflozin), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 9 of them publish a price we can compare per daily dose

Dapagliflozin · ATC A10BK01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dapagliflozin costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.33 in United States to $4.38 in Switzerland — a ×13 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Dapagliflozin · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$4.38
  • IT Italy$3.42
  • US United States$0.33 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ダパグリフロジンプロピレングリコール水和物
Manufacturer
ニプロ
Country
Japan (JP)
ATC code
A10BK01
ATC class
Dapagliflozin
Defined daily dose
10 mg, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

426 interactions on record for dapagliflozin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Dapagliflozin · interactions on record

426 records

  • 1 severe
  • 378 moderate
  • 47 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • PapaverineA03AD01moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dapagliflozin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dapagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Dapagliflozin +pharma, Dapagliflozin Devatis
  • Belgium · Dapagliflozin Ab, Dapagliflozin Eg
  • Bulgaria · Dapagliflozin Sandoz, Dapagliflozin Tchaikapharma
  • Cyprus · Daforbis, Dapagliflozin Farmoz
  • Czechia · Dagetia, Dagrafors
  • Germany · Daglin, Dapagliflozin 123-Acurae Pharma
  • Denmark · Dapagliflozin, Dapagliflozin "sandoz"
  • Estonia · Dagrafors, Dapagliflozin Alembic
  • Spain · Daforbis, Dapagliflozina Aurovitas
  • Finland · Dapagliflozin Devatis, Dapagliflozin Krka
  • France · Dapagliflozine Arrow, Dapagliflozine Biogaran
  • United Kingdom (Northern Ireland) · Daforbis, Dapagliflozin
  • Greece · Brolertix, Daforbis
  • Croatia · Daforbis, Dagrafors
  • Hungary · Dagrafors, Dapagliflozin Sandoz
  • Ireland · Dapagliflozin Clonmel, Dapagliflozin Krka
  • Iceland · Dapagliflozin Krka, Dapagliflozin Krka D.D.
  • Italy · Dapagliflozin Aurobindo, Dapagliflozin Doc
  • Liechtenstein · Dapagliflozin Viatris, Edistride
  • Lithuania · Dagrafors, Dapagliflozin Accord
  • Luxembourg · Dapagliflozin Eg
  • Latvia · Daglin, Dagrafors
  • Malta · Dapagliflozin Ascend, Dapagliflozin Aurobindo
  • Netherlands · Dapagliflozin Alembic, Dapagliflozin Amarox
  • Norway · Dapagliflozin Alembic, Dapagliflozin Devatis
  • Poland · Daforbis, Dagrafors
  • Portugal · Dalzior, Dapagliflozin Ipca
  • Romania · Daforbis, Dagetia
  • Sweden · Daforbis, Dapagliflozin Adalvo
  • Slovenia · Dagrafors, Dapagliflozin Hcs
  • Slovakia · Dagetia, Dagrafors

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b4301ee7-5784-4f93-87e0-2e42681862e0
GET /v1/drugs/b4301ee7-5784-4f93-87e0-2e42681862e0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "5mg1錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3969019F1086",
  "category": "内用薬",
  "price_yen": 14859,
  "generic_name": "ダパグリフロジンプロピレングリコール水和物",
  "product_name_jp": null,
  "therapeutic_class": "3969",
  "transitional_expiry": "14859"
}

See everything about dapagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.